These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33708948)
1. Wang X; Ge X; Wang H; Huang J; Song Q; Xu C; Jiang Z; Su J; Wang H; Tan L; Jiang D; Hou Y Ann Transl Med; 2021 Feb; 9(4):321. PubMed ID: 33708948 [TBL] [Abstract][Full Text] [Related]
2. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma. Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival. Tian S; Ma R; Liu Y; Chen F; Huang X; Yang Q; Nian W; Fan Z Transl Cancer Res; 2024 Jun; 13(6):2971-2984. PubMed ID: 38988936 [TBL] [Abstract][Full Text] [Related]
5. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma. Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of Xu C; Liu Y; Huang J; Wang H; Tan L; Xu Y; Jiang Z; Wang X; Hou Y; Jiang D; Wang Q Oncotarget; 2017 Oct; 8(50):87699-87709. PubMed ID: 29152113 [TBL] [Abstract][Full Text] [Related]
7. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma. Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy. Yoon HI; Park KH; Lee EJ; Keum KC; Lee CG; Kim CH; Kim YB Cancer Res Treat; 2016 Apr; 48(2):473-82. PubMed ID: 26323639 [TBL] [Abstract][Full Text] [Related]
9. Mouse double minute 2 amplification in oesophageal squamous cell carcinoma is associated with better outcome. Jiang D; Chen L; Huang J; Wang H; Song Q; Shi P; Wang H; Hou Y Histopathology; 2020 Dec; 77(6):963-973. PubMed ID: 32652667 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of Wang H; Zhou Y; Liu Q; Xu J; Ma Y Onco Targets Ther; 2018; 11():5171-5181. PubMed ID: 30210237 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of sex determining region Y-box 2, E-cadherin, and vimentin in esophageal squamous cell carcinoma. Li C; Ma YQ World J Clin Cases; 2022 Sep; 10(27):9657-9669. PubMed ID: 36186174 [TBL] [Abstract][Full Text] [Related]
13. High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients. Song Q; Liu Y; Jiang D; Wang H; Huang J; Xu Y; Sujie A; Zeng H; Xu C; Hou Y Oncotarget; 2017 Sep; 8(43):74539-74553. PubMed ID: 29088806 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma. Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965 [TBL] [Abstract][Full Text] [Related]
15. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study. Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
17. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma. Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571 [TBL] [Abstract][Full Text] [Related]
19. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]